Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6701216 | 7312176 | F | 6701216-1 | 20091201 | 20100419 | 20100427 | EXP | TCI2010A00319 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 60 | YR | M | N | 20100426 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6701216 | 1013588480 | PS | ACTOS | 1 | ORAL | 30 MG (30 MG, 1 IN 1 D), PER ORAL | D | D | 21073 | ||
| 6701216 | 1013627509 | C | MEDET (METFORMIN HYDROCHLORIDE) | 2 | |||||||
| 6701216 | 1013627510 | C | GLIMICRON (GLICLAZIDE) | 2 | |||||||
| 6701216 | 1013627511 | C | SEIBULE (MIGLITOL) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6701216 | 1013588480 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6701216 | HO |
| 6701216 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 6701216 | CARDIAC FAILURE |
| 6701216 | CARDIAC TAMPONADE |
| 6701216 | CARDIOMEGALY |
| 6701216 | FATIGUE |
| 6701216 | INCREASED UPPER AIRWAY SECRETION |
| 6701216 | LUNG NEOPLASM MALIGNANT |
| 6701216 | METASTASES TO HEART |
| 6701216 | PERICARDIAL EFFUSION |
| 6701216 | TACHYCARDIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6701216 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6701216 | 1013588480 | 20090225 | 20100122 | 331 | DAY |